Study compares obinutuzumab, rituximab for relapsed non-Hodgkin lymphoma patients | Researchers identify mutations related to myeloma | Brain tissue grown from human stem cells
 
 
August 20, 2015
AABB SmartBrief
News for the transfusion medicine and cellular therapy community
SIGN UP|FORWARD|ARCHIVE

Top StorySponsored By
Study compares obinutuzumab, rituximab for relapsed non-Hodgkin lymphoma patients
Patients with relapsed CD20-positive indolent B-cell non-Hodgkin lymphoma who had previously responded to rituximab achieved a higher overall response rate with obinutuzumab than rituximab in a 175-patient midstage study reported in the Journal of Clinical Oncology. Treatment with obinutuzumab was not associated with increased progression-free survival. CancerTherapyAdvisor.com (8/19)
Share: LinkedInTwitterFacebookGoogle+Email
How well do you know Adaptive Web Design?
Retailers of all sizes are now realizing what giants like Amazon have known for years: that the ultimate mobile web solution blends the best of all available methods into an adaptive approach. In this whitepaper, we answer:
• What is adaptive web design?
• How does it compare to other solutions in cost, effort, and business impact?
• How do I know if an adaptive approach is right for my business?
• What steps can I take to start down this path?
Access it now!

Science & Health
Researchers identify mutations related to myeloma
A whole genome sequencing study involving 463 myeloma patients identified 15 significantly mutated genes. IRF4 and EGR1 mutations were associated with prolonged survival, while TP53, ATM, ATR and ZNFHX4 mutations were associated with reduced survival rates. The findings were reported in the Journal of Clinical Oncology. CancerTherapyAdvisor.com (8/19)
Share: LinkedInTwitterFacebookGoogle+Email
Emerging Trends
Brain tissue grown from human stem cells
Ohio State University researchers have grown human brain tissue by manipulating pluripotent stem cells derived from human skin cells. The lab-grown tissue includes spinal cord cells, signaling circuitry and a retina, according to findings presented at the Military Health System Research Symposium. The Guardian (London) (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Chip with grooves increases production of stem cell-produced heart cells, study finds
Scientists with Imperial College London have generated more cardiomyocytes from heart stem cells through the use of a silicon chip with closely spaced grooves. The findings were reported in the journal Biomaterials. Imperial College London (U.K.) (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Preclinical study tests hydrogel, growth protein for heart muscle repair
Injection of a growth protein mixed with a biodegradable hydrogel was associated with reductions in heart damage among rats, according to a study in the journal ACS Biomaterials Science & Engineering. Rats that received the protein-hydrogel mix had at least 25% less scarring compared with rats that did not. Chemical & Engineering News (8/19)
Share: LinkedInTwitterFacebookGoogle+Email
Industry News & Practice
Brain hemorrhage drug developer prepares initial public offering
Plans for an initial public offering have been filed by Edge Therapeutics with the goal of raising as much as $115 million. The firm's lead candidate is a reformulated treatment for ruptured aneurysms in the brain. FierceDrugDelivery (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
Grant goes to researchers working on stem cell-derived skin
Researchers with the University of Minnesota's Stem Cell Institute have been awarded a $2.4 million grant by the Richard M. Schulze Family Foundation to support their work in growing healthy skin tissue from skin-derived stem cells. Star Tribune (Minneapolis-St. Paul, Minn.) (8/18)
Share: LinkedInTwitterFacebookGoogle+Email
AABB Members Share Knowledge and Tips in the AABB HUB
Activity in AABB's new online platform, the AABB HUB, is picking up with members exchanging views on a variety of topics within transfusion medicine, cellular therapies and patient blood management (PBM). The PBM group currently features an active thread on how members are monitoring their PBM activities. Have an opinion to share? Reply to active threads and post your questions in the HUB. Join the discussion today.
 
Association News
Reminder: Early discount registration for AABB Annual Meeting ends Aug. 26
Discounted registration rates for the 2015 AABB Annual Meeting -- to be held October 24-27 in Anaheim, Calif. -- will end next week. Individuals can register for the meeting online.
Share: LinkedInTwitterFacebookGoogle+Email
JOBS
powered by
Manager, Laboratory Technical Services
BLOOD CENTERS OF THE PACIFIC - San Francisco, CA
Clinical Laboratory Scientist, Processing Lab
BLOOD CENTERS OF THE PACIFIC - CA
Quality Systems Specialist
BLOODWORKS NORTHWEST - Seattle, WA
Hospital Services Manager
BLOOD BANK OF HAWAII - Honolulu, HI
Reference Laboratory Supervisor
BLOOD BANK OF HAWAII - Honolulu, HI
Information Systems Quality and Design Specialist
BLOOD SYSTEMS, INC. - SCOTTSDALE, AZ
Director of Blood Product Collections
KEY BIOLOGICS, LLC - Memphis, TN
SmartQuote
Success in business requires training and discipline and hard work. But if you're not frightened by these things, the opportunities are just as great today as they ever were."
-- David Rockefeller,
banker and philanthropist
Share: LinkedInTwitterFacebookGoogle+Email
Learn more about AABB® ->Homepage | Join AABB | Conferences | Marketplace | AABB CareerLink
Subscriber Tools
Please contact one of our specialists for advertising opportunities, editorial inquiries, job placements, or any other questions.
 
Editor:  Tom Parks
Advertising:  Meryl Harold
  P: 202.407.7828
 
 

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2015 SmartBrief, Inc.®
Privacy policy |  Legal Information